Stan Rockson, MD

Stan Rockson, MD is the Chief of Consultative Cardiology and an Associate Professor at Stanford School of Medicine. His research focuses on the characterization of the biochemical and cellular responses to impaired lymphatic function; development and molecular characterization of the strategies for therapeutic lymphangiogenesis; imaging of immune traffic and its role in lymphatic disorders.

Kuniaki Seyama MD, PhD

Kuniaki Seyama MD, PhD is an Assistant Professor in the Department of Respiratory Medicine at Juntendo University. He is interested in pulmonary LAM and in performing mutation analysis of the tuberous sclerosis complex (TSC) genes to explore a possible correlation between this mutation and clinical phenotype. He is exploring the relationship between lymphangiogenesis-induced by LAM cells and pathogenesis in the disease. Among other things, he will present clinical data on the epidemiology of LAM in Japan and discuss hormonal modulation therapy in this patient cohort.

Joel Moss MD, PhD

Joel Moss MD, PhD is a member of the Translational Medicine Branch of the National Heart, Lung, and Blood Institute (NHLBI). His laboratory has ongoing basic and clinical research programs to investigate signal transduction pathways in health and disease. Areas of clinical and translational research include lymphangioleimyomatosis (LAM) and other destructive lung diseases (e.g., cystic fibrosis), with primary emphasis on the roles of susceptibility/modifier genes and infection/inflammation on disease progression and severity.